Navigation Links
Childhood anxiety disorders can and should be treated, according to UT Southwestern national expert
Date:12/24/2008

journal by senior author John Walkup of Johns Hopkins Medical Institute. The pivotal research, which was conducted at seven medical institutions across the U.S., was the first study to directly compare medication treatment, cognitive behavioral therapy that examines thinking patterns in order to modify behavior, and the combination of both treatments in children and teens with anxiety disorders. The results showed that antidepressant medications and cognitive behavioral therapy were equally effective treatments for anxiety and that the combination of both treatments was most effective.

Dr. Emslie said he hopes future studies will build on this work to determine what type to treatment is best for individual patients.

"Partial treatment is not adequate," he said. "If children aren't treated to the point of complete remission, they are likely to relapse. It's imperative that we help children overcome their anxiety disorders for their own lifetime good."


'/>"/>

Contact: LaKisha Ladson
lakisha.ladson@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Yeast mimics severity of mutations leading to fatal childhood illness
2. UCSF receives $24.4 million to fight early childhood cavities
3. Childhood Obesity May Cause Thyroid Problems
4. Antacid Medication in Pregnancy May Increase Childhood Asthma
5. More Than $2.4 Million Raised by National Halloween Promotion Partners to Help St. Jude Fight Childhood Cancer
6. New partnership to foster healthier food habits in early childhood
7. Video: Childhood Influenza Immunization Coalition Supports Second Annual Childrens Flu Vaccination Day
8. Childhood Constipation Carries a Big Price Tag
9. Gene Behind Childhood Anemias Found
10. Adult survivors of childhood leukemia have lower bone mineral density, study finds
11. Siskin Center for Child and Family Research to Focus on Early Childhood Development and Special Education
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Childhood anxiety disorders can and should be treated, according to UT Southwestern national expert
Childhood anxiety disorders can and should be treated, according to UT Southwestern national expert
(Date:12/14/2009)... 14 When Kurth Krause, an aerospace ... for landing on the moon, he,was confident that ... later, Kurth realized there was one thing that ... transplant and even though dialysis machines,would keep her ... transplant. Kurth,wrote: "My wife is 69 and is ...
(Date:12/14/2009)... An estimated 29,000 future cancers could be linked to scans ... -- Commonly performed CT scans are exposing patients to far ... cause tens of thousands of cancers a year, two new ... Dec. 14/28 issue of the Archives of Internal Medicine ... Dr. Rita F. Redberg, are calling on clinicians to limit ...
(Date:12/14/2009)... protection, study finds, , , MONDAY, Dec. 14 (HealthDay News) ... their morning without a cup or two of java: ... developing type 2 diabetes. , That,s the conclusion ... coffee you drink, the lower your risk of diabetes. ... percent reduction in the risk of diabetes, the researchers ...
(Date:12/14/2009)... Type 2 diabetes and obesity are linked to an ... suggested that insulin glargine (a synthetic insulin preparation marketed ... a higher risk of certain cancers than other insulins ... were unable to control for important factors such as ... On the other hand, a large randomized trial designed ...
(Date:12/14/2009)... lead to better treatments for asthma, COPD, researchers say ... identified five genetic variants that influence lung function, a ... lung diseases. , The international team of researchers compared ... 2.5 million sites across the human genome in more ... team to the five common genetic variants associated with ...
Breaking Medicine News(10 mins):Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 3Health News:Studies Quantify Cancer Risks From CT Scans 2Health News:Studies Quantify Cancer Risks From CT Scans 3Health News:Studies Quantify Cancer Risks From CT Scans 4Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3Health News:UNC scientists coordinate study of link between insulin use and cancer in people with diabetes 2
... Allos,Therapeutics, Inc. (Nasdaq: ALTH ) today announced ... Manufacturing. In this position, Mr. Bennett,will lead the ... potential commercialization of Allos, product candidates., "We ... Paul L. Berns,President and CEO. "Bruce,s experience in ...
... - SXC Health Solutions, Inc.,("SXC" or the "Company") ... provider of,pharmacy benefits management services, announces that Mark ... Senior Vice President,and Chief Financial Officer, will present ... the Grand Hyatt in New York City. SXC,s ...
... of today,s seniors are,retiring into what they hope will ... to stay connected to the "real world." They need ... and resources. In,addition, these adults are looking for all ... repairs to coordinating personal,transportation and even finding healthcare products ...
... Jan. 28 Demo 08 -- Today, at ... of Acesis Point-of-Care(TM), a,revolutionary on-demand electronic health record ... data capture for,healthcare professionals by providing a secure, ... reporting and analysis., "Acesis Point-of-Care is a ...
... Leading Plastic Surgeons, Jolie, Kidman, Anderson, Loren, Bundchen, ... We hear it every day, "Oh, I wish ... abs -- I,d do anything.",With increasing availability of aesthetic ... payment plans,available, some of these wishes are coming true. ...
... Mich., Jan. 28 Shazaaam! LLC, an ... was,recently named Public Relations and Marketing Communications ... Shazaaam will provide social marketing, proactive ... services to enhance,ETC,s branding and visibility among ...
Other Medicine News:Health News:Allos Therapeutics Appoints Bruce K. Bennett as Vice President, Manufacturing 2Health News:Allos Therapeutics Appoints Bruce K. Bennett as Vice President, Manufacturing 3Health News:SXC Health Solutions to present at the 2008 UBS Global Healthcare Services Conference 2Health News:Senior Citizens Bureau Empowers Today's Seniors: National Non-profit Serves as Community Resource for Seniors, Their Children, Caregivers and Even Advocates 2Health News:Senior Citizens Bureau Empowers Today's Seniors: National Non-profit Serves as Community Resource for Seniors, Their Children, Caregivers and Even Advocates 3Health News:Acesis Point-of-Care, The Physician's Ultimate Replacement for Pen and Paper, Unveiled at DEMO 08 2Health News:Acesis Point-of-Care, The Physician's Ultimate Replacement for Pen and Paper, Unveiled at DEMO 08 3Health News:Celebrity Influences on Plastic Surgery 2Health News:Celebrity Influences on Plastic Surgery 3Health News:Celebrity Influences on Plastic Surgery 4Health News:Shazaaam! Named PR Agency of Record for Enuresis Treatment Center 2
(Date:12/14/2009)... INDIANAPOLIS, Dec. 14 The ... RELPREVV (olanzapine) For Extended Release Injectable Suspension for ... and Company (NYSE: LLY ) announced ... the delivery of olanzapine for up to four ... short-acting formulations, long-acting formulations of antipsychotics allow for ...
(Date:12/14/2009)... Pf enex Inc. announced today that it ... an exclusive worldwide license to Pf enex Expression ... the production of specific proteins to be ... ,, Under the terms of the agreement ... in upfront and milestone payments as well as additional ...
(Date:12/14/2009)... SCRANTON, Pa., Dec. 14 CPG ... highly engineered building products, introduces VYCOM, a ... of the previous VYCOM Corporation and Scranton ... a wholly recognized business unit within CPG ... Scranton Products Commercial. The VYCOM business unit ...
Breaking Medicine Technology:FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 2FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 3FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 4FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 5FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 6FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 7FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 8Cardiogenesis Corporation Names Paul J McCormick Executive Chairman 49968 1Cardiogenesis Corporation Names Paul J McCormick Executive Chairman 49968 2Cardiogenesis Corporation Names Paul J McCormick Executive Chairman 49968 3Remarks As Prepared for Delivery by Attorney General Eric Holder at the Heat Press Conference on Detroit Takedown 49965 1Remarks As Prepared for Delivery by Attorney General Eric Holder at the Heat Press Conference on Detroit Takedown 49965 2Remarks As Prepared for Delivery by Attorney General Eric Holder at the Heat Press Conference on Detroit Takedown 49965 3AEterna Zentaris Receives US 2410 Million from Institutional Investors 12773 1AEterna Zentaris Receives US 2410 Million from Institutional Investors 12773 2AEterna Zentaris Receives US 2410 Million from Institutional Investors 12773 3
... WESTMINSTER, Colo., Dec. 27 Allos,Therapeutics, Inc. (Nasdaq: ... Data,Monitoring Committee (DMC) has completed the pre-specified 65-patient,safety ... 2 PROPEL trial of,PDX (pralatrexate) in patients with ... recommended that the trial continue per the,protocol. This ...
... Traditional Approval -, YARDLEY, Pa., Dec. 21 ... Supplemental New Drug Application (sNDA) to the U.S. ... (PI) PREZISTA(TM),(darunavir) tablets, which seeks traditional approval and ... adults. The application includes 48-week data from two,Phase ...
Other Medicine Technology:Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma 2Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma 3Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma 4Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma 5Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration 2Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration 3Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration 4Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration 5
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: